These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 35704993)

  • 1. Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication.
    Gargaro M; Scalisi G; Manni G; Briseño CG; Bagadia P; Durai V; Theisen DJ; Kim S; Castelli M; Xu CA; Meyer Zu Hörste G; Servillo G; Della Fazia MA; Mencarelli G; Ricciuti D; Padiglioni E; Giacchè N; Colliva C; Pellicciari R; Calvitti M; Zelante T; Fuchs D; Orabona C; Boon L; Bessede A; Colonna M; Puccetti P; Murphy TL; Murphy KM; Fallarino F
    Immunity; 2022 Jun; 55(6):1032-1050.e14. PubMed ID: 35704993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation.
    Mondanelli G; Coletti A; Greco FA; Pallotta MT; Orabona C; Iacono A; Belladonna ML; Albini E; Panfili E; Fallarino F; Gargaro M; Manni G; Matino D; Carvalho A; Cunha C; Maciel P; Di Filippo M; Gaetani L; Bianchi R; Vacca C; Iamandii IM; Proietti E; Boscia F; Annunziato L; Peppelenbosch M; Puccetti P; Calabresi P; Macchiarulo A; Santambrogio L; Volpi C; Grohmann U
    Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3848-3857. PubMed ID: 32024760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-γ induces a tryptophan-selective amino acid transporter in human colonic epithelial cells and mouse dendritic cells.
    Bhutia YD; Babu E; Ganapathy V
    Biochim Biophys Acta; 2015 Feb; 1848(2):453-62. PubMed ID: 25450809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cDC1 to cDC2: "Everything I do, Ido1 it for you".
    Prentzell MT; Opitz CA
    Immunity; 2022 Jun; 55(6):967-970. PubMed ID: 35704997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity.
    Mondanelli G; Albini E; Orecchini E; Pallotta MT; Belladonna ML; Ricci G; Grohmann U; Orabona C
    Front Immunol; 2021; 12():713989. PubMed ID: 34394118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDO1 promotes CSFV replication by mediating tryptophan metabolism to inhibit NF-κB signaling.
    Zhao F; Huang Y; Ji J; Liu X; Li X; Zou L; Wu K; Liu Xd; Zeng S; Wang X; Hu W; Song Y; Lu Z; Zhou B; Li P; Wang W; Zhao M; Chen J; Yi L; Fan S
    J Virol; 2024 Jul; 98(7):e0045824. PubMed ID: 38814067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme.
    Pallotta MT; Rossini S; Suvieri C; Coletti A; Orabona C; Macchiarulo A; Volpi C; Grohmann U
    FEBS J; 2022 Oct; 289(20):6099-6118. PubMed ID: 34145969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the kynurenine pathway in Indoleamine 2, 3 dioxygenase deficient mice with inflammatory arthritis.
    Kolodziej L
    Transgenic Res; 2013 Oct; 22(5):1049-54. PubMed ID: 23417792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO.
    Kim M; Tomek P
    Front Immunol; 2021; 12():636081. PubMed ID: 33708223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indoleamine 2,3-dioxygenase (IDO1) - Can dendritic cells and monocytes expressing this moonlight enzyme change the phase of Parkinson's Disease?
    Gonçalves M; Rodrigues-Santos P; Januário C; Cosentino M; Pereira FC
    Int Immunopharmacol; 2024 May; 133():112062. PubMed ID: 38652967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
    Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
    Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone.
    Wolowczuk I; Hennart B; Leloire A; Bessede A; Soichot M; Taront S; Caiazzo R; Raverdy V; Pigeyre M; ; Guillemin GJ; Allorge D; Pattou F; Froguel P; Poulain-Godefroy O
    Am J Physiol Regul Integr Comp Physiol; 2012 Jul; 303(2):R135-43. PubMed ID: 22592557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes.
    Pallotta MT; Orabona C; Bianchi R; Vacca C; Fallarino F; Belladonna ML; Volpi C; Mondanelli G; Gargaro M; Allegrucci M; Talesa VN; Puccetti P; Grohmann U
    J Cell Mol Med; 2014 Oct; 18(10):2082-91. PubMed ID: 25215657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine.
    Manni G; Mondanelli G; Scalisi G; Pallotta MT; Nardi D; Padiglioni E; Romani R; Talesa VN; Puccetti P; Fallarino F; Gargaro M
    Front Immunol; 2020; 11():292. PubMed ID: 32226425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment.
    Gostner JM; Becker K; Überall F; Fuchs D
    Expert Opin Ther Targets; 2015 May; 19(5):605-15. PubMed ID: 25684107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A peripheral blood mononuclear cell-based in vitro model: A tool to explore indoleamine 2, 3-dioxygenase-1 (IDO1).
    Gonçalves M; Furgiuele A; Rasini E; Legnaro M; Ferrari M; Luini A; Rodrigues-Santos P; Caramelo F; Marino F; Pereira FC; Cosentino M
    Eur J Pharmacol; 2024 Apr; 968():176420. PubMed ID: 38367683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency Inhibits Pathological Cardiac Hypertrophy.
    Wang Y; Song J; Yu K; Nie D; Zhao C; Jiao L; Wang Z; Zhou L; Wang F; Yu Q; Zhang S; Wen Z; Wu J; Wang CY; Wang DW; Cheng J; Zhao C
    Hypertension; 2023 Oct; 80(10):2099-2111. PubMed ID: 37485661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
    Curti A; Trabanelli S; Onofri C; Aluigi M; Salvestrini V; Ocadlikova D; Evangelisti C; Rutella S; De Cristofaro R; Ottaviani E; Baccarani M; Lemoli RM
    Haematologica; 2010 Dec; 95(12):2022-30. PubMed ID: 20801903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in IDO1
    Malik AE; Slauenwhite D; McAlpine SM; Hanly JG; Marshall JS; Issekutz TB
    Front Immunol; 2024; 15():1352251. PubMed ID: 38840915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process.
    Salminen A
    Ageing Res Rev; 2022 Mar; 75():101573. PubMed ID: 35085834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.